TickerFacts.

Prokidney Corp. (PROK): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$9.50M2021-12-31: $02022-12-31: $02023-12-31: $9.50M2024-12-31: $02025-12-31: $0$0
2021-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$0n/a2026-03-18, From 2025-01-01
2024-12-31$0-100.0%2026-03-18, From 2024-01-01
2023-12-31$9.50Mn/a2026-03-18, From 2023-01-01
2022-12-31$0n/a2025-03-17, From 2022-01-01
2021-12-31$0n/a2024-03-22, From 2021-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Prokidney Corp. (PROK)2025-12-31$0n/a
Pelthos Therapeutics Inc. (PTHS)2025-12-31$0-100.0%
C4 Therapeutics, Inc. (CCCC)2025-12-31$193.0K-0.5%
Invivyd, Inc. (IVVD)2024-12-31$0-100.0%
Champions Oncology, Inc. (CSBR)2025-04-30$0-100.0%
Creative Medical Technology Holdings, Inc. (CELZ)2025-12-31$10.0K-94.3%
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Repligen Corp (RGEN)2025-12-31$0n/a
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%

Compare PROK, PTHS, CCCC, IVVD side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗